XERS
NASDAQ · Pharmaceuticals
Xeris Biopharma Holdings Inc
$5.44
-0.14 (-2.51%)
Open$5.58
Previous Close$5.58
Day High$5.61
Day Low$5.40
52W High$10.08
52W Low$3.81
Volume—
Avg Volume2.86M
Market Cap972.71M
P/E Ratio1,755.79
EPS$-0.02
SectorPharmaceuticals
Analyst Ratings
Strong Buy
13 analysts
Price Target
+757.5% upside
Current
$5.44
$5.44
Target
$46.65
$46.65
$35.62
$46.65 avg
$60.75
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 300.99M | 217.55M | 186.74M |
| Net Income | 570.1K | 370.9K | 58.69M |
| Profit Margin | 0.2% | 0.2% | 31.4% |
| EBITDA | 36.86M | 25.31M | 67.69M |
| Free Cash Flow | — | — | 40.84M |
| Rev Growth | +38.4% | +38.4% | +1.9% |
| Debt/Equity | 16.10 | 16.10 | 0.60 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |